Alantra advises Laboratorios Forenqui on its sale to Sherpa Capital
SECTORConsumer Goods & Retail
Madrid – Alantra, the global investment banking and asset management specialist, is pleased to announce that it has advised Laboratorios Forenqui (“Forenqui” or “the Company”), a specialised producer and distributor of personal hygiene and home care products, on its sale to Sherpa Capital (“Sherpa”), a Spanish private equity firm.
With more than 30 years of experience, Laboratorios Forenqui manufactures and distributes personal care products, enjoying a strong presence in Europe, South America, Africa and the Middle East. The Company has a renowned R&Ddepartment, responsible for the manufacture of well-known firms such as Anian Cosmetics, Foresan and Forenauto, in addition to some of the private label products of Lidl’s and Consum. Additionally, Forenqui has a workforce of 80 people and has 3,000 square meters of facilities in Valencia, manufacturing all their products in Spain.
Sherpa is a Spanish private equity fund investing in medium-sized companies with a strategic, operational, financial, or equity-related challenge. This transaction was performed by Sherpa’s Private Equity fund, raised in 2019 to invest in companies with great potential for organic and corporate growth, aiming to create large business groups that are leaders in their sector. Together with its traditional Special Situations funds, Sherpa manages more than €500m.
Alantra acted as exclusive advisor to the founder of the Company, organising a competitive process which received strong interest from local and international private equities. During the process, Alantra had to manage issues such as the positive impact of Covid-19 on demand and sales of a personal care business, the Company’s drivers of growth in the coming years, and the departure of the founder after the transaction, with the subsequent transition into new leadership of the Company.
With this transaction, Laboratorios Forenqui will continue its growth and internationalisation supported by Sherpa’s expertise in maximizing a company’s competitive position and optimizing its economies of scale.
“We are thrilled to have supported Laboratorios Forenqui in their partnership with Sherpa Capital, which will guide the Company into a new stage of growth.” Commented Roberto León, Managing Partner at Alantra. He continued: “This transaction adds on to Alantra’s strong credentials in the M&A Consumer Goods and Retail sector.”
May 2022Buy-side advisoryMay 2022SECTOR Consumer Goods & RetailService M&A
Mar 2022Sell-side advisoryValue £40mMar 2022SECTOR Consumer Goods & RetailService M&AValue £40m
Jan 2022Sell-side advisoryJan 2022SECTOR Consumer Goods & Retail; TechnologyService M&A
Jan 2022Debt financingValue $200 millionJan 2022SECTOR Consumer Goods & RetailService Debt AdvisoryValue $200 million